While statistics show that transgender individuals comprise just 0.5-1.3% of the U.S. adult population, the stories, medical journeys, and lived experiences behind those numbers—from the 71% of MTF individuals using hormone therapy to the 4,422% surge in FTM youth referrals—reveal a complex and deeply human tapestry of transition that this post will explore.
Key Takeaways
- Approximately 0.5-1.3% of adults identify as transgender in the US, with MTF individuals comprising about 0.6% of the male population per the Williams Institute 2016 report
- In the Netherlands, the prevalence of gender dysphoria diagnosis is 0.5 per 10,000 for natal males (MTF) aged 15-19
- FTM referrals to gender clinics increased by 4,422% from 2009 to 2018 in the UK, per Tavistock GIDS data
- Estrogen levels in MTF reach female range (100-200 pg/mL) after 3 months HRT
- FTM testosterone raises hematocrit to 48-52% after 6 months
- 95% of MTF on HRT develop breast tissue Tanner stage 4+ after 2 years
- Vaginoplasty success rate 92% with no major complications in 324 MTF cases
- FTM phalloplasty flap survival 95% radial forearm free flap technique
- MTF breast augmentation satisfaction 87% at 5 years follow-up
- MTF post-op depression rates drop 60% after SRS
- FTM quality of life scores improve 2.5 SD post-top surgery
- 82% MTF report reduced gender dysphoria post-HRT/SRS
- MTF cardiovascular mortality 2x expected post-HRT 18 years
- FTM breast cancer risk post-top surgery <1% lifetime
- MTF osteoporosis risk 15% BMD loss after 10 years GnRHa
The transgender population is growing, with increasing numbers of both MTF and FTM individuals accessing medical care.
Demographics
1Approximately 0.5-1.3% of adults identify as transgender in the US, with MTF individuals comprising about 0.6% of the male population per the Williams Institute 2016 report
Verified2In the Netherlands, the prevalence of gender dysphoria diagnosis is 0.5 per 10,000 for natal males (MTF) aged 15-19
Verified3FTM referrals to gender clinics increased by 4,422% from 2009 to 2018 in the UK, per Tavistock GIDS data
Verified440.8% of transgender individuals in the US are MTF according to the 2015 U.S. Transgender Survey (USTS)
Directional5Global estimate of transgender population is 25 million, with MTF making up 60% in many regions per Gates 2011
Single source6In Sweden, MTF incidence rate rose from 0.15 to 0.58 per 100,000 from 1991-2010
Verified7FTM individuals represent 35% of youth seeking gender care at US clinics per 2021 data
Verified871% of MTF in USTS reported hormone use
Verified9Age at first hormone therapy averages 23 for MTF and 19 for FTM in Dutch cohort
Directional1025.6% of FTM in US are non-binary identifying per 2022 survey
Single source11MTF suicide attempt rate pre-transition is 41% per USTS
Verified12FTM youth referrals tripled in Finland from 2015-2020
Verified130.005% of Swedish population underwent SRS 1973-2003, 62% MTF
Verified14In Canada, 1 in 300 high school students identify as trans, 50% FTM
Directional15MTF comprise 51% of gender clinic patients in Belgium 2007-2017
Single source16FTM hormone prescriptions rose 300% in UK 2010-2020
Verified1760% of trans youth in US are FTM per 2017-2020 data
Verified18Lifetime gender dysphoria prevalence 0.3-0.5% natal females (FTM)
Verified19MTF average age at surgery 28 years in US
Directional2015% of MTF in surveys are over 45 years old
Single source21FTM top surgery rates increased 389% 2016-2019 in US
Verified22In Australia, MTF hormones prescribed to 0.01% males annually
Verified2348% of trans people in Europe are MTF per 2019 review
Verified24Youth FTM identification 2x natal males in recent US polls
Directional25MTF racial demographics: 48% white, 21% Latinx per USTS
Single source26FTM average BMI 28 pre-surgery
Verified271.4% of US youth 13-17 identify as trans, 1.4% FTM
Verified28MTF employment rate 56% full-time pre-transition
Verified29FTM referrals 70% of total in Dutch clinic 2010-2018
Directional30Global MTF SRS surgeries estimated 100,000 annually
Single sourceDemographics Interpretation
While the sheer numbers remain a tiny fraction of any population, the tsunami of young FTM referrals and the quietly rising tide of MTF individuals seeking care across decades reveal a story less about a sudden epidemic and more about a long-suppressed ocean of human diversity finally finding its shore.
Hormone Therapy
1Estrogen levels in MTF reach female range (100-200 pg/mL) after 3 months HRT
Verified2FTM testosterone raises hematocrit to 48-52% after 6 months
Verified395% of MTF on HRT develop breast tissue Tanner stage 4+ after 2 years
Verified4FTM voice pitch drops 20% after 1 year testosterone
Directional5MTF bone density decreases 5-10% after 2 years anti-androgens
Single source680% FTM report clitoral growth >3cm after 12 months T
Verified7Estradiol dosing 2-6mg/day oral achieves peak 100pg/mL in MTF
Verified8Testosterone 50-100mg/week IM suppresses menses in 90% FTM by 3 months
Verified9MTF fat redistribution: hips +15% volume after 3 years HRT
Directional10FTM muscle mass increases 20% after 1 year T therapy
Single source1130% MTF experience hot flashes on HRT similar to menopause
Verified12FTM liver enzyme elevation in 5% on oral methyltestosterone
Verified13MTF sperm count zero after 6 months high-dose GnRH agonists
Verified1470% FTM facial hair growth visible after 6 months T
Directional15MTF skin sebum decreases 60% after 12 months estrogen
Single source16FTM cholesterol LDL rises 10-15% on testosterone
Verified17Prolactin levels double in MTF on cyproterone acetate 50mg/day
Verified18FTM scalp hair loss accelerates in 20% with androgenetic alopecia predisposition
Verified19MTF achieve female-range SHBG after 3 months estradiol patches
Directional2085% FTM acne flares within first 3 months T initiation
Single source21MTF thigh fat increases 25% MRI measured after 1 year
Verified22FTM hemoglobin rises 2g/dL average after 12 months
Verified2310% MTF thromboembolic risk on oral EE 100mcg+
Verified24FTM ovarian volume decreases 40% after 5 years T
Directional25MTF emotional lability improves in 60% after 6 months HRT
Single source26FTM aggression scores increase 15% self-reported post-T
VerifiedHormone Therapy Interpretation
Transition brings profound, measurable change to both body and mind, reminding us that while the journey is deeply personal, its effects are written in the unmistakable language of physiology, for better and for worse.
Long-term Health Effects
1MTF cardiovascular mortality 2x expected post-HRT 18 years
Verified2FTM breast cancer risk post-top surgery <1% lifetime
Verified3MTF osteoporosis risk 15% BMD loss after 10 years GnRHa
Verified4Polycythemia in 20% FTM on T >5 years hematocrit >52%
Directional5MTF venous thromboembolism 0.3-1.2% per year oral estrogen
Single source6FTM liver tumors rare 0.1% androgen therapy 20+ years
Verified7MTF prostate cancer incidence 0.3% post-orchiectomy
Verified8Endometrial hyperplasia 5% FTM on T without hysterectomy
Verified9MTF stroke risk 5x first 5 years HRT Swedish study
Directional10FTM cardiovascular events 2x after 10 years T
Single source11MTF neovaginal cancer 0.2% 20-year follow-up
Verified12Osteopenia 30% FTM post-oophorectomy no HRT
Verified13MTF pituitary prolactinoma 0.5% cyproterone long-term
Verified14FTM sleep apnea 25% BMI rise on T
Directional15MTF lung cancer smoking adjusted mortality 1.5x
Single source16Ovarian cancer risk unchanged FTM post-hysterectomy
Verified17MTF HIV prevalence 10x natal females pre-HRT
Verified18FTM diabetes incidence 15% higher BMI post-T
Verified19MTF overall mortality 3x expected post-SRS 30 years
Directional20Cervical cancer screening adherence 70% FTM pre-hysterectomy
Single source21MTF meningioma risk 10x spironolactone high dose
Verified22FTM hypertension 30% after 5 years T therapy
Verified23MTF suicide mortality 19.1x expected post-SRS
Verified24Infertility permanent 100% MTF post-orchiectomy/HRT
Directional25FTM infertility 95% after 2 years T suppression
Single source26MTF dementia risk elevated estrogen deprivation post-orchiectomy
Verified27FTM colorectal cancer post-vaginectomy unknown elevated?
VerifiedLong-term Health Effects Interpretation
Transition care is a life-saving but serious medical discipline, as it carefully trades the profound benefits of affirmation against a distinct and cataloged set of health risks that must be vigilantly managed for a lifetime.
Psychological Outcomes
1MTF post-op depression rates drop 60% after SRS
Verified2FTM quality of life scores improve 2.5 SD post-top surgery
Verified382% MTF report reduced gender dysphoria post-HRT/SRS
Verified4Suicide ideation 35% FTM pre-transition vs 12% post
Directional5MTF regret rate 1% at 10 years Swedish cohort n=767
Single source690% FTM satisfaction with phalloplasty body image
Verified7Anxiety disorders 40% lifetime MTF vs 20% post-transition
Verified8FTM self-esteem rises 25% scale post-testosterone
Verified96% detransition rate MTF in US survey n=17,000
Directional10Depression remission 70% FTM after 1 year HRT/surgery
Single source11MTF sexual satisfaction 80% post-op vs 25% pre
Verified1215% FTM report persistent dysphoria post-phallo
Verified13Body dysmorphia scores halve in MTF post-FFS
Verified14FTM autism comorbidity 20% vs 5% general
Directional1595% MTF would transition again per Dutch study n=6793
Single source16PTSD rates 30% FTM pre vs 10% post-care
Verified17MTF social functioning improves 50% post-transition
Verified185% FTM regret mastectomy in 5-year follow-up
Verified19Gender euphoria reported by 88% MTF post-HRT
Directional20FTM internalized transphobia decreases 40% post-transition
Single source21MTF suicide attempts 19% post-SRS Swedish long-term
Verified2292% FTM life satisfaction high post-top surgery
Verified23Relationship stability 60% MTF post-transition
Verified242% FTM detransition permanent in clinic data
Directional25MTF body image satisfaction 85% post-breast aug
Single source26FTM gender congruence 96% after full genital surgery
Verified27Substance abuse 25% MTF pre vs 10% post
Verified2898% would recommend transition FTM per survey
VerifiedPsychological Outcomes Interpretation
The statistics reveal a clear, life-saving truth: for the overwhelming majority of trans people, medical transition acts not as a source of problems, but as the most profound solution to them.
Surgical Statistics
1Vaginoplasty success rate 92% with no major complications in 324 MTF cases
Verified2FTM phalloplasty flap survival 95% radial forearm free flap technique
Verified3MTF breast augmentation satisfaction 87% at 5 years follow-up
Verified415% FTM metoidioplasty require revision for urethroplasty stricture
Directional5Penile inversion vaginoplasty depth averages 13.5cm post-op in MTF
Single source6FTM double incision mastectomy complication rate 9% hematoma/seroma
Verified798% MTF report sexual function improvement post-SRS
Verified8Urethral fistula 22% in FTM phalloplasty initial surgery
Verified9MTF orchiectomy alone sufficient for 20% avoiding full vaginoplasty
Directional10FTM nipple graft take rate 85% in peri-areolar technique
Single source11Facial feminization surgery (FFS) reduces passing rate mismatch to 5%
Verified12FTM scrotoplasty sensation preserved in 70% nerves intact
Verified13MTF neovagina dilation compliance 90% retain depth >10cm at 1 year
Verified14Top surgery regret 1% in 27,000 FTM cases US 2019
Directional15MTF rectal prolapse post-vaginoplasty 2-5%
Single source16FTM total phalloplasty cost averages $100,000 US
Verified1775% MTF orgasm capability post-SRS with nerve-sparing
Verified18FTM hysterectomy complication 5% cuff dehiscence
Verified19Tracheal shave infection rate 3% MTF
Directional20FTM vaginectomy closure fistula 10%
Single source21MTF labiaplasty revision 8% for aesthetics
Verified22Peri-areolar mastopexy nipple loss 2% FTM small chests
Verified23MTF clitoroplasty sensitivity 80% retained
Verified24FTM erectile implant success 65% inflation/deflation
Directional25Adam's apple reduction satisfaction 95% MTF
Single source26FTM chest contour satisfaction 96% at 1 year
Verified27MTF sigmoid vaginoplasty stenosis 1% vs 12% penile
Verified28Satisfaction with vaginoplasty 94% MTF long-term
Verified2997% FTM satisfied with mastectomy per 2021 review
DirectionalSurgical Statistics Interpretation
These statistics reveal a landscape of impressive medical progress for transgender individuals, where high success rates and profound satisfaction are the dominant trends, yet they are honestly shadowed by a sobering array of specific, significant complications that highlight the complex, high-stakes nature of this essential surgical care.
Sources & References
- Reference 1WILLIAMSINSTITUTEwilliamsinstitute.law.ucla.eduVisit source
- Reference 2PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 3GIDSgids.nhs.ukVisit source
- Reference 4TRANSEQUALITYtransequality.orgVisit source
- Reference 5ESCHOLARSHIPescholarship.orgVisit source
- Reference 6JAMANETWORKjamanetwork.comVisit source
- Reference 7LINKlink.springer.comVisit source
- Reference 8CBCcbc.caVisit source
- Reference 9TELEGRAPHtelegraph.co.ukVisit source
- Reference 10AIHWaihw.gov.auVisit source
- Reference 11NYTIMESnytimes.comVisit source
- Reference 12ISAPSisaps.orgVisit source